SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-015099
Filing Date
2017-08-03
Accepted
2017-08-03 06:31:33
Documents
60
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nerv-10q_20170630.htm 10-Q 1381882
2 EX-31.1 nerv-ex311_8.htm EX-31.1 16937
3 EX-31.2 nerv-ex312_7.htm EX-31.2 16739
4 EX-32.1 nerv-ex321_6.htm EX-32.1 9530
  Complete submission text file 0001564590-17-015099.txt   4779419

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nerv-20170630.xml EX-101.INS 760207
6 XBRL TAXONOMY EXTENSION SCHEMA nerv-20170630.xsd EX-101.SCH 45341
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nerv-20170630_cal.xml EX-101.CAL 35393
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nerv-20170630_def.xml EX-101.DEF 176885
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20170630_lab.xml EX-101.LAB 350906
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20170630_pre.xml EX-101.PRE 298124
Mailing Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36517 | Film No.: 171002700
SIC: 2834 Pharmaceutical Preparations